Search

everythinglearnresearchcommunity

for

Search:↓

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Chinese herbal medicine might help reduce chemotherapy side effects in breast cancer patients, but more high-quality research is needed.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

ACTH-dependent Cushing's syndrome linked to metastatic cervical cancer is rare and has high risks.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

More research is needed to understand how adipose-derived stem cells affect liver cancer treatment.

miR-325-3p can slow down brain tumor growth by targeting FOXM1.

Targeting lipid metabolism can help treat advanced, resistant cancers.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

A woman's symptoms of increased body hair and testosterone were caused by a rare adrenal tumor, which was removed successfully.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Actinic keratosis can lead to skin cancer, is more common in fair-skinned people, and can be reduced with sunscreen and treated effectively.

Hidradenitis suppurativa is linked to various diseases like obesity, depression, arthritis, and Crohn's disease, but often occurs alone.